SBIR/STTR Research Award

Novel ultra-stable enzymes and methods for proteomics

Award identifier 846e0691b1ed2d904b175cc59c7b69f31ba0dd577d986b08170d957dccb958f2Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$150,000

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CINDER BIOLOGICAL INC.
Proposal award date
2018-07-01
Contract end date
2019-06-30
UEI
RCKBKNRYJKN1
Solicitation number
PA16-157
Topic code
400

Research abstract

PROJECT SUMMARY ABSTRACT ! Proteomics is critical for health research as it enables analysis of proteins involved in a broad range of biological processesAlthough proteomics has laid the foundation for many advances in disease diagnosistreatmentand preventionimprovements in sample preparation and processing of protein and sugar biomolecules have lagged far behind impressive developments in mass spectrometryMStechnologiesMost proteomics laboratories are heavily reliant on enzyme technologies that are overyears oldnamely trypsinWhile trypsin has been a very powerful molecular toolthe potential of new classes and capabilities for relevant enzymes have yet to be explored and realizedAt CinderBiowe have developed technologies that yield enzymes with remarkable stability and activity at high temperaturesCand extremes in acidic pHthat also tolerate an unprecedented spectrum of chemicals and solventsThese newly available enzymes hold great promise to rapidly advance many areas of proteomics researchImportantlyoptimal conditions for our enzymatic activities are conditions that denature and solubilize most if not all mesophilic proteinsa current limitation in sample processing for some MS analysesAt CinderBiowe produce a variety of glycohydrolasesincluding sugar de branching enzymesproteasesand other classes of hyper stable enzymes thatfunction optimally at extreme temperatures and pH that assist in exposing target bondsi econditions where mesophilic proteins are denaturedminimally cross react and have little autolysisallowing stable multi enzyme formulationsandare tolerant of many harsh oxidizing reducing chemicalsdetergentsand solventsandhave very fast reaction ratesThese capabilities open possibilities for entirely new methods for proteomic sample preparation for mass spectrometryCinderBio enzyme formulations promise to reduce required sample sizesincrease coveragemake quantitation more reliablesimultaneously de glycosylate and proteolyze samplesand generally streamline upstream sample preparationHere we propose to formulate our enzymes for the explicit purpose of modernizing the proteomic methodologies of sample preparationWe see immediate opportunities to address the growing list of difficult target proteins like histonestransmembrane and glycosylated proteinse gneural tissueswhile increasing digestion efficienciesThese Phase I experiments will focus on establishing proteomics protocols for our enzymes on a set of well known substratesinvestigating simultaneous deglycosylation and proteolysis of a set of glycoproteinsand benchmarking for performance against standard tryptic protocols and enzymes PROJECT NARRATIVE ! Proteomics is critical for health research as it enables analysis of proteins involved in a broad range of biological processesAlthough proteomics has laid the foundation for many advances in disease diagnosistreatmentand preventionimprovements in sample preparation have lagged far behind impressive developments in mass spectrometry technologiesHere we propose to bring an entirely new class of ultrastable enzymes and their capabilities to the forefront of proteomics researchWe think these advances will not only address known protease limitationsbut also expand the scope and effectiveness of proteomic analyses for biological and medical research

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2015–2020). Reported award amounts total $2,701,513. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.